We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$92.5M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$88M
3
BABA icon
Alibaba
BABA
+$73.8M
4
MRK icon
Merck
MRK
+$49.8M
5
MXIM
Maxim Integrated Products
MXIM
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZEN
901
DELISTED
ZENDESK INC
ZEN
– –
-5,369
Closed -$775K
DRE
902
DELISTED
Duke Realty Corp.
DRE
– –
-53,495
Closed -$2.53M
PFPT
903
DELISTED
Proofpoint, Inc.
PFPT
– –
-98,981
Closed -$17.2M
MXIM
904
DELISTED
Maxim Integrated Products
MXIM
– –
-460,606
Closed -$48.5M
USCR
905
DELISTED
U S Concrete, Inc.
USCR
– –
-83,516
Closed -$6.16M
CHMA
906
DELISTED
Chiasma, Inc. Common Stock
CHMA
– –
-23,500
Closed -$111K
TLND
907
DELISTED
Talend S.A. American Depositary Shares
TLND
– –
-268,728
Closed -$17.6M
HOME
908
DELISTED
At Home Group Inc.
HOME
– –
-93,286
Closed -$3.44M
ALXN
909
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-503,510
Closed -$92.5M
WORK
910
DELISTED
Slack Technologies, Inc.
WORK
– –
-591,282
Closed -$26.2M
CNST
911
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
– –
-280,008
Closed -$9.46M
LMNX
912
DELISTED
Luminex Corp
LMNX
– –
-478,532
Closed -$17.6M
PRAH
913
DELISTED
PRA Health Sciences, Inc.
PRAH
– –
-87,515
Closed -$14.5M
FLY
914
DELISTED
Fly Leasing Limited
FLY
– –
-259,121
Closed -$4.39M
KNL
915
DELISTED
Knoll, Inc.
KNL
– –
-184,616
Closed -$4.8M
WBK
916
DELISTED
Westpac Banking Corporation
WBK
– –
-97
Closed -$2K
GRA
917
DELISTED
W.R. Grace & Co.
GRA
– –
-325,773
Closed -$22.5M
CBB
918
DELISTED
Cincinnati Bell Inc.
CBB
– –
-165,973
Closed -$2.56M
ORBC
919
DELISTED
ORBCOMM, Inc.
ORBC
– –
-841,269
Closed -$9.46M
VG
920
DELISTED
Vonage Holdings Corporation
VG
– –
-75,700
Closed -$1.1M
33 34 35 36
37

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.